Show simple item record

dc.contributor.authorMcGovern, Andrew
dc.contributor.authorDennis, John
dc.contributor.authorShields, Beverley
dc.contributor.authorHattersley, Andrew
dc.contributor.authorPearson, Ewan
dc.contributor.authorJones, Angus
dc.date.accessioned2023-01-13T16:12:12Z
dc.date.available2023-01-13T16:12:12Z
dc.date.issued2019en_UK
dc.identifier.urihttps://rdmc.nottingham.ac.uk/handle/internal/10382
dc.language.isoenen_UK
dc.publisherFigshareen_UK
dc.relation.urihttp://doi.org/10.6084/m9.figshare.c.4470188en_UK
dc.rightsCC-BYen_UK
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_UK
dc.titleWhat to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue? A MASTERMIND studyen_UK
uon.preservation.rarelyaccessedtrue


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Research Data Catalogue
    A metadata only collection of research data resources, available from or stored at external facilities/repositories

Show simple item record

CC-BY
Except where otherwise noted, this item's license is described as Creative Commons by Attribution